Risk of postpartum disease activity with subcutaneous versus intravenous Natalizumab in pregnant women with multiple sclerosis

View at publisher
Authors: Vito AG Ricigliano, Doriana Landi, Marine Boudot de la Motte, Jonathan Ciron, Bertrand Bourre, Dr Olivier Casez, Silvia Bartolomeo, Giangaetano D'Aleo, Roberta Fantozzi, Matteo Foschi, Francesca Napoli, Caroline Papeix
+2 more Girolama Alessandra Marfia, E. Maillart
Cited by: 1
References: 19

Fields of Study & Subjects

Multiple Sclerosis Research Studies Pregnancy and Medication Impact Polyomavirus and related diseases

Publication details

Journal / source
Multiple Sclerosis and Related Disorders
Publisher
Elsevier BV
Volume
109
Pages
107086–107086
Publication date
20 February 2026
Language
EN